Evaluation of the Antimicrobial Activity of Bacteriocin-Producing Lactic Acid Bacteria Isolated from Human Intestine against Pathogenic Microorganisms http://www.doi.org/10.26538/tjnpr/v7i6.18
Article Sidebar
Main Article Content
Abstract
Currently, it is crucial to screen efficient, safe, and accessible therapies from a variety of prospective antimicrobial agents due to the rapid development of microbial resistance against chemotherapeutic drugs (mainly antibiotics). Bacteriocins are a type of antimicrobial peptide created by bacteria that are ribosomally synthesized. Bacteriocins have evolved into one of the tools used to combat bacteria because of their distinctive traits. Therefore, bacteriocins may replace antibiotics to treat multiple drugs resistance pathogens. Accordingly, the purpose of this study was to investigate the antibacterial effects of secondary metabolites from two bacteriocinproducing strains (Lactobacillus acidophilus (LA102) and Lacticaseibacillus casei (LC232)) on 24 pathogenic and spoilage microorganisms either alone or in combination. The 50% inhibitory concentration, minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC), or minimum fungicidal concentration (MFC) were determined. The fractional inhibitory concentration (FIC) and its effect were also defined. Results showed that all the 12 bacterial and ten fungal strains were inhibited by both bacteriocin-producing strains and only four fungal strains were not affected by all studied 12 strains. It was found that the bactericidal activity of both bacteriocin-producing strains against S. aureus, L. monocytogenes, and the fungi strains M. phaseolina was the highest among all the tested strains. It was also noticed that a combination of (LA102) and (LC232) gives a 20% synergistic effect and 40 % additive relationship and indifferent relationship without any microbes showing an antagonistic relationship. Moreover, to screen for better functional and bacteriocin-producing strains, this study offers a practical, thorough, and shared profile of newly developed antimicrobial agents.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Anukam KC, Reid G. Probiotics: 100 years (1907–2007) after Elie Metchnikoff’s observation. Trends Microbiol. 2007; 1:466-74.
Fuller R. Probiotics in man and animals. J Apply Bacter. 1989; 66(5):365-78.
Tannock GW. Probiotics and prebiotics: where are we going? Caister Academic Press; 2002.
Isolauri E, Sütas Y, Kankaanpää P, Arvilommi H, Salminen S. Probiotics: effects on immunity. American J Clin Nutri. 2001; 73(2):444s-50s.
Joint FAO/WHO Expert Meetings on Microbiological Risk Assessment (Group), World Health Organization. Risk characterization of microbiological hazards in food: guidelines. WHO; 2009.
Awaisheh SS, Khalifeh MS, Al-Ruwaili MA, Khalil OM, AlAmeri OH, Al-Groom R. Effect of supplementation of probiotics and phytosterols alone or in combination on serum and hepatic lipid profiles and thyroid hormones of hypercholesterolemic rats. J Dair Sci. 2013; 96(1):9-15.
Ibrahim SA, Gyawali R, Awaisheh SS, Ayivi RD, Silva RC, Subedi K, Aljaloud SO, Siddiqui SA, Krastanov A. Fermented foods and probiotics: An approach to lactose intolerance. J Dair Rese. 2021; 88(3):357-65.
Martinez RC, Bedani R, Saad SM. Scientific evidence for health effects attributed to the consumption of probiotics and prebiotics: an update for current perspectives and future challenges. British J Nutri. 2015; 114(12):1993-2015.
Oelschlaeger TA. Mechanisms of probiotic actions–a review. Inte J Med Micro. 2010; 300(1):57-62.
Farnworth ER. The evidence to support health claims for probiotics. Journal Nutri. 2008; 138(6):1250S-4S.
Barretto DA, Gadwala M, Vootla SK. The silkworm gut microbiota: A potential source for biotechnological applications. InMeth in Micro. 2021; 49:1-26. Academic Press.
Burton JP, Drummond BK, Chilcott CN, Tagg JR, Thomson WM, Hale JD, Wescombe PA. Influence of the probiotic Streptococcus salivarius strain M18 on indices of dental health in children: a randomized double-blind, placebocontrolled trial. J Med Micro. 2013; 62(6):875-84.
Kalliomäki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomized placebo-controlled trial. Lan. 2001; 357(9262):1076-9.
Lee DK, Park JE, Kim MJ, Seo JG, Lee JH, Ha NJ. Probiotic bacteria, B. longum and L. acidophilus inhibit infection by rotavirus in vitro and decrease the duration of diarrhea in pediatric patients. Clin Res Hepa Gastro. 2015; 39(2):237- 44.
Boaventura C, Azevedo R, Uetanabaro A, Nicoli J, Braga LG. The benefits of probiotics in human and animal nutrition. New Adv Clin Gastro. 2012.
Oelschlaeger TA. Bacteria as tumor therapeutics?. Bioeng. 2010; 1(2):146-7.
Tiwari SK. Bacteriocin-producing probiotic lactic acid bacteria in controlling dysbiosis of the gut microbiota. Front in Cell Infec Micro. 2022:415.
Awaisheh SS, Obeidat MM, Al-Tamimi HJ, Assaf AM, ElQudah JM, Rahahleh RJ. In vitro cytotoxic activity of probiotic bacterial cell extracts against Caco-2 and HRT-18 colorectal cancer cells. Milk Sci Inter-Milch. 2016; 69(7):33- 7.
World Health Organization. WHO global report on Traditional and complementary medicine 2019. WHO; 2019.
Gupta V, Datta P. Next-generation strategy for treating drugresistant bacteria: Antibiotic hybrids. Indian J Med Res. 2019; 149(2):97.
Alqaraleh S, Mehyar GF, Alqaraleh M, Awaisheh SS, Rahahleh RJ. Antibacterial and Antioxidant Activities of Extracts from Selected Wild Plant Species Found in Jordan. Trop J Nat Prod Res. 2023; 7(3):2520-2524
Marshall SH, Arenas G. Antimicrobial peptides: A natural alternative to chemical antibiotics and a potential for applied biotechnology. Elect J Biotech. 2003; 6(3):271-84.
Awaisheh SS. Development of probiotic soft cheese manufactured using goat's milk with the addition of thyme. Milk Sci Inter-Milch. 2011; 66(1):51-4.
Faintuch J, Faintuch S, editors. Microbiome and metabolome in diagnosis, therapy, and other strategic applications. Academic Press; 2019.
Awaisheh SS, Ibrahim SA. Screening of antibacterial activity of lactic acid bacteria against different pathogens found in vacuum-packaged meat products. Foodborne Path Dis. 2009; 6(9):1125-32.
Al-Nabulsi AA, Awaisheh SS, Osaili TM, Olaimat AN, Rahahaleh RJ, Al-Dabbas FM, Al-Kharabsheh LA, Gyawali R, Ibrahim SA. Inactivation of Cronobacter sakazakii in reconstituted infant milk formula by plant essential oils. J Appl Bot Food Qual. 2015; 88(1).
Yasunaka K, Abe F, Nagayama A, Okabe H, Lozada-Pérez L, López-Villafranco E, Muñiz EE, Aguilar A, Reyes-Chilpa R. Antibacterial activity of crude extracts from Mexican medicinal plants and purified coumarins and xanthones. J Ethnopharm. 2005; 97(2):293-9.
Sueke H, Kaye S, Neal T, Murphy C, Hall A, Whittaker D, Tuft S, Parry C. Minimum inhibitory concentrations of standard and novel antimicrobials for isolates from bacterial keratitis. Investig Ophth & Vis Sci. 2010; 51(5):2519-24.
Martínez B, Rodríguez A, Suárez E. Antimicrobial peptides produced by bacteria: The Bacteriocins. New weapons to control bacterial growth. 2016:15-38.
Simons A, Alhanout K, Duval RE. Bacteriocins, antimicrobial peptides from bacterial origin: an overview of their biology and their impact against multidrug-resistant bacteria. Micr. 2020; 8(5):639.
Deep S, Kundu S. Assessment of preliminary in vitro probiotic characteristics of the folate-producing yogurt starter culture Streptococcus and Lactobacillus species. J Pharma Bio Sci. 2015; 10(3):26-31.
Ilavenil S, Park HS, Vijayakumar M, Valan Arasu M, Kim DH, Ravikumar S, Choi KC. Probiotic potential of Lactobacillus strains with antifungal activity isolated from animal manure. Sci World J. 2015.
Gyawali R, Ibrahim SA. Natural products as antimicrobial agents. Food Cont. 2014; 46:412-29.
de Souza de Azevedo PO, Mendonça CM, Moreno AC, Bueno AV, de Almeida SR, Seibert L, Converti A, Watanabe IS, Gierus M, de Souza Oliveira RP. Antibacterial and antifungal activity of crude and freeze-dried bacteriocin-like inhibitory substance produced by Pediococcus pentosaceus. Sci Rep. 2020; 10(1):12291.
Dalié DK, Deschamps AM, Richard-Forget F. Lactic acid bacteria–Potential for control of mold growth and mycotoxins: A review. Food Cont. 2010; 21(4):370-80.
Dorman HD, Deans SG. Antimicrobial agents from plants: antibacterial activity of plant volatile oils. J Appl Micro. 2000; 88(2):308-16.
Liu RD, Meng XY, Li CL, Long SR, Cui J, Wang ZQ. Molecular characterization and determination of the biochemical properties of cathepsin L of Trichinella spiralis. Veter Res. 2022; 53(1):1-9.
Hassan M, Kjos M, Nes IF, Diep DB, Lotfipour F. Natural antimicrobial peptides from bacteria: characteristics and potential applications to fight against antibiotic resistance. J Appl Micro. 2012; 113(4):723-36.
Toroglu S. In vitro antimicrobial activity and antagonistic effect of essential oils from plant species. J Enviro Bio. 2007; 28(3):551-9.
Oussama BK, Fatima S, Djilali B, Rym B. The Combined effect of Rosmarinus officinalis Lessential oil and Bacteriocin BacLP01 from Lactobacillus plantarum against Bacillus subtilis ATCC11778. Trop J Nat Prod Res. 2023; 7(3):2551-2557